Skip to main content
. 2020 Feb 24;9(2):605. doi: 10.3390/jcm9020605

Table 2.

Performance of VIMme-miR663ame panel for the detection of bladder cancer in Validation Cohorts #1 and #2. (PPV—positive predictive value; NPV—negative predictive value).

Samples Biomarker Performance miR663ame-VIMme (%)
Validation #1 Sensitivity 87.0
Specificity 86.0
PPV 91.6
NPV 79.0
Accuracy 86.6
Validation #2 Sensitivity 80.0
Specificity 75.3
PPV 65.0
NPV 86.8
Accuracy 77.0

PPV—Positive Predictive Value; NPV—Negative Predictive Value.